Model Number 40025 |
Device Problems
Gradient Increase (1270); Patient Device Interaction Problem (4001); Device Stenosis (4066); Central Regurgitation (4068)
|
Patient Problems
Aneurysm (1708); Aortic Valve Stenosis (1717); Thrombosis/Thrombus (4440); Aortic Valve Insufficiency/ Regurgitation (4450)
|
Event Date 10/26/2023 |
Event Type
Injury
|
Event Description
|
Medtronic received information that 9 years post implant of this 25mm aortic bioprosthetic valve, non-obstructive valve thrombosis was observed.It was stated that the aortic mean gradient increased to 31 mmhg.Further examination via computed tomography (ct) discovered mild thickened and kinked leaflets.No additional adverse patient effects were reported.It was later reported that a transthoracic echocardiogram (tte) performed 5 months later showed moderate to severe aortic stenosis (as) and severe aortic regurgitation (ar).It was also stated that a aneurysm of the ascending aorta was observed.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that 9 years post implant of this 25mm aortic bioprosthetic valve, non-obstructive valve thrombosis was observed.It was stated that the aortic mean gradient increased to 31 mmhg.Further examination via computed tomography (ct) discovered mild thickened and kinked leaflets.No additional adverse patient effects were reported.It was later reported that a transthoracic echocardiogram (tte) performed 5 months later showed moderate to severe aortic stenosis (as) and severe aortic regurgitation (ar).It was also stated that a aneurysm of the ascending aorta was observed.It was indicated that the aneurysm measures 48mm.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Corrected b5 to include "it was indicated that the aneurysm measures 48mm." medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|